1 North Wealth Services’s VanEck Biotech ETF BBH Stock Holding History

1 North Wealth Services’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.8K	Hold	79	–	–	0.01%	138
2025 Q4	$14.9K	Buy	79 +1	+1%	+$185	0.01%	141
2025 Q3	$13K	Hold	78	–	–	0.01%	138
2025 Q2	$12K	Hold	78	–	–	﹤0.01%	140
2025 Q1	$12.3K	Buy	+78	New	+$12.7K	0.01%	136
2019 Q4	$11K	Hold	76	–	–	0.01%	188
2019 Q3	$9K	Buy	+76	New	+$9.45K	0.01%	158
2019 Q1	$10K	Hold	76	–	–	0.01%	146
2018 Q4	$8K	Buy	+76	New	+$9.18K	0.01%	160

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

1 North Wealth Services's BBH Position: Q1 2026 in Review

1 North Wealth Services held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 79 shares worth $14.8K. The position accounts for 0.01% of the portfolio, ranked #138.

1 North Wealth Services first reported a position in BBH in Q4 2018 and has held it in 9 quarters since. The position peaked at $14.9K in Q4 2025. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

1 North Wealth Services held 79 shares of VanEck Biotech ETF worth $14.8K as of Q1 2026.
1 North Wealth Services left its VanEck Biotech ETF share count unchanged in Q1 2026.
VanEck Biotech ETF made up 0.01% of 1 North Wealth Services's portfolio in Q1 2026, its #138 holding.
1 North Wealth Services first reported a position in VanEck Biotech ETF in Q4 2018 and has held it in 9 quarters since.
1 North Wealth Services's VanEck Biotech ETF position peaked at $14.9K in Q4 2025.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on 1 North Wealth Services's 13F filing for Q1 2026, filed 4 May 2026.